Retinoids exert pleiotropic effects on mammalian physiology. They play a key role in epithelial cell differentiation, have profound effects on limb and nervous system morphogenesis, are potent inhibitors of carcinogenesis, and are currently used as chemopreventive and therapeutic agents in several types of cancer. Signalling by these hormones is mediated by two classes of nuclear receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs) which bind all trans- and 9 cis-retinoic acids, respectively. These receptors usually associate with regulatory elements upstream from speCific target genes and act as ligand-inducible transcription factors. The proposed project is designed to clarify the factors that modulate the multiple interactions of retinoid nuclear receptors and obtain insights into the mechanisms by which signalling by retinoids may be regulated. The processes of self- association of receptor proteins and their interactions with their ligands and with cognate DNA will be studied. Binding affinities characterizing these interactions as well as the kinetic parameters leading to the formation of receptor-ligand-DNA complexes will be investigated using quantitative methods. The interactions of the retinoid X receptors with the thyroid hormone receptor will be studied to better understand the mechanisms by which signalling pathways by thyroid hormone and by retinoids may converge to affect gene transcription. To clarify one aspect of the mechanisms by which retinoids may suppress carcinogenesis, the interactions of retinoid receptors with the proton- oncogene products c-Fos and c-Jun (AP-1 transcription factor) and the effects of retinoid receptors on binding of the AP-1 factor to its cognate DNA will be investigated. The roles of post-translational modification of receptor proteins in modulating their various interactions will be examined in order to better understand the mechanisms underlying the regulation of retinoid receptor function in the cell.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA068150-01
Application #
2112017
Study Section
Molecular and Cellular Biophysics Study Section (BBCA)
Project Start
1995-09-30
Project End
1999-07-31
Budget Start
1995-09-30
Budget End
1996-07-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Cornell University
Department
Nutrition
Type
Other Domestic Higher Education
DUNS #
City
Ithaca
State
NY
Country
United States
Zip Code
14850
Yasmin, Rubina; Kannan-Thulasiraman, Padmamalini; Kagechika, Hiroyuki et al. (2010) Inhibition of mammary carcinoma cell growth by RXR is mediated by the receptor's oligomeric switch. J Mol Biol 397:1121-31
Kannan-Thulasiraman, Padmamalini; Seachrist, Darcie D; Mahabeleshwar, Ganapati H et al. (2010) Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth. J Biol Chem 285:19106-15
Noy, Noa (2007) Ligand specificity of nuclear hormone receptors: sifting through promiscuity. Biochemistry 46:13461-7
Schug, Thaddeus T; Berry, Daniel C; Shaw, Natacha S et al. (2007) Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129:723-33
Sessler, Richard J; Noy, Noa (2005) A ligand-activated nuclear localization signal in cellular retinoic acid binding protein-II. Mol Cell 18:343-53
Yasmin, Rubina; Williams, Rebecca M; Xu, Ming et al. (2005) Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. J Biol Chem 280:40152-60
Yasmin, Rubina; Yeung, Kay T; Chung, Richard H et al. (2004) DNA-looping by RXR tetramers permits transcriptional regulation ""at a distance"". J Mol Biol 343:327-38
Wu, Zhiping; Yang, Yanwu; Shaw, Natacha et al. (2003) Mapping the ligand binding pocket in the cellular retinaldehyde binding protein. J Biol Chem 278:12390-6
Manor, Danny; Shmidt, Elena N; Budhu, Anuradha et al. (2003) Mammary carcinoma suppression by cellular retinoic acid binding protein-II. Cancer Res 63:4426-33
Golovleva, Irina; Bhattacharya, Sanjoy; Wu, Zhiping et al. (2003) Disease-causing mutations in the cellular retinaldehyde binding protein tighten and abolish ligand interactions. J Biol Chem 278:12397-402

Showing the most recent 10 out of 24 publications